How do we stand out from local area centers?
GIOSTAR CHICAGO leverages GIOSTAR’s customized, proprietary treatment protocols to treat each and every one of our patients. Our protocols were developed based on research grants, endowments, and private funding. Regenerative medicine is a highly complex field of medicine that requires years and years of extensive ongoing research. Most local centers do not fully grasp the nuances and intricacies of this field. They do not have teams of dedicated research scientists conducting ongoing US-based clinical studies to enable their centers to continue providing the most advanced science to their patients.
The GIOSTAR Chicago center does not take a “one size fits all” approach to medicine. GIOSTAR was formed a decade ago to do intensive research, and strives for higher quality control and excellence. Our scientists hail from the University of California San Diego (UCSD), the Salk Institute, the University of California Irvine (UCI), the University of California Los Angeles (UCLA), and other prestigious U.S.A. universities. Armed with extensive training, they deliver cutting edge, research-based treatment protocols to GIOSTAR Chicago and beyond. This rigorous approach enables us to stay abreast of the latest techniques and advancements in the ever-evolving field of regenerative medicine. In parallel with patient care, our teams of highly-skilled research scientists devote countless hours each day to make history by advancing the field of medicine and changing people’s lives for the better.
Treatments by GIOSTAR Scientific Partner
outside of USA
Articles published in medical journals by GIOSTAR Scientific Partner
Years experience in scientific research by GIOSTAR Scientific Partner
GIOSTAR Scientific Partner locations offering treatments throughout the world
THE SAFEST AND MOST EFFECTIVE STEM CELL THERAPY IN 7 COUNTRIES
GIOSTAR OFFERS YOU ACCESS TO GOVERNMENT AND UNIVERSITY LEVEL RESEARCH THAT BEGAN IN 1998
Dr. Srivastava is credited with many of the fundamental creations that have made the entire industry of modern stem cell science possible. Governments worldwide rely on his expertise and guidance to determine policies, best practices, and safety procedures.
AWARDS & RECOGNITION
Dr. Srivastava and GIOSTAR have been recognized by several governments worldwide including Japan, India, Poland, Saudi Arabia, and Mexico, for our work. Further, the team has received the prestigious Best In Business award by the United States Government for research and service for treatment of debilitating diseases.
PUBLICATIONS & JOURNALS
Dr. Srivastava’s discoveries, innovations, and publications are the most utilized by doctors and scientists in the field of stem cells. There are many journals dedicated to his work, he is a world-renowned speaker, and is the reviewer of several journals in the industry.
The pioneering research of Dr. Srivastava led to the FIRST FDA Approved Human Clinical Trial, conducted at the University of California Irvine, with the Christopher and Dana Reeve Foundation for spinal cord injury in 2007.
You now have direct access to this level of expertise for your stem cell therapy.